Vascular Solutions Expands Complex Intervention Offerings With Turnpike™ LP Catheter
December 22, 2015 08:00 ET
|
Vascular Solutions, Inc.
- Fourth version in the series of Turnpike catheters launched for use in complex coronary and peripheral interventions - Provides lower profile design and increased flexibility...
Vascular Solutions Receives 510(k) Clearance for R350 Guidewire
November 24, 2015 09:00 ET
|
Vascular Solutions, Inc.
New, Enhanced Version Designed With Nitinol Core and Hydrophilic Coating for Superior Flexibility, Kink-Resistance, and Deliverability in Extreme Vessel Tortuosity350cm-Length Guidewire Designed for...
Vascular Solutions to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 17, 2015 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate at the 27th Annual Piper Jaffray Healthcare...
Vascular Solutions to Transfer PolarCath(TM) Distribution Rights to NuCryo Vascular LLC
November 16, 2015 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) and NuCryo Vascular LLC today announced that they have mutually terminated the agreement under which...
Vascular Solutions to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum
November 05, 2015 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Minn., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Canaccord Genuity Medical Technology...
Vascular Solutions to Present at the 2015 Stifel Healthcare Conference
November 03, 2015 16:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Nov. 03, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2015 Stifel Healthcare Conference in New York...
Vascular Solutions Reports Third Quarter Results
October 20, 2015 16:05 ET
|
Vascular Solutions, Inc.
Revenue increased 16% to $37 million, matching the top end of guidanceAdjusted EPS of $0.27 exceeded the top end of guidance; GAAP EPS of $0.16Raising 2015 revenue guidance to $146 - $147 million,...
Vascular Solutions, Inc. to Webcast Third Quarter Conference Call
September 29, 2015 04:05 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its third quarter conference call on Tuesday, October 20th at...
Vascular Solutions Surpasses 100,000 Successfully Reprocessed ClosureFAST(R) Catheters
August 17, 2015 09:00 ET
|
Vascular Solutions, Inc.
Reprocessing of Varicose Vein Ablation Catheter Continues to Gain CustomersExcellent Record of Safety and ReliabilityReprocessing Lowers Costs and Reduces Medical Waste for U.S. Vein Clinics ...
Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters
August 03, 2015 09:00 ET
|
Vascular Solutions, Inc.
MINNEAPOLIS, Aug. 03, 2015 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has expanded the PolarCath peripheral dilatation system product line with the launch...